Canbi Pharma Tech Limited
2370013-12-8 Sunvozertinib

2370013-12-8 Sunvozertinib

CAS:2370013-12-8
MF:C29H35ClFN7O3
MW:584.08
EINECS:
MDL No.:

Send Inquiry
Description

Properties

Appearance Off-white to light brown Solid
Density 1.35±0.1 g/cm3
storage temp. Store at -20°C
pka12.29±0.70
 

Application:

Sunvozertinib is a drug used to treat locally advanced or metastatic non-small cell lung cancer (NSCLC), primarily targeting patients with EGFR (epidermal growth factor receptor) exon 20 insertion mutations
 

 

Synonyms:

sunvozertinib

2370013-12-8

DZD-9008

ASYM-122507

DZ-0586

N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide

A1801

A-1801

2-Propenamide, N-(5-((4-((5-chloro-4-fluoro-2-(1-hydroxy-1-methylethyl)phenyl)amino)-2-pyrimidinyl)amino)-2-((3R)-3-(dimethylamino)-1-pyrrolidinyl)-4-methoxyphenyl)-

Example 52 

N-(5-((4-(5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino)pyrimidin-2-yl)amino)-2-((3R)-3-(dimethylamino)pyrrolidin-1-yl)-4-methoxyphenyl)prop-2-enamide

 

 

Hot Tags: 2370013-12-8 sunvozertinib, China 2370013-12-8 sunvozertinib manufacturers, suppliers, api data mining api integration, api data leak prevention for api, api product catalog api integration, api international api integration, api microservices, api predictive analytics api integration

Inquiry
goTop

(0/10)

clearall